Abcombi Biosciences
Buffalo
About Abcombi Biosciences
Abcombi Biosciences was formed on June 22nd, 2015 based off of research conducted in the Chemical & Biological Engineering Department at the University at Buffalo. Our corporate headquarters are located in Buffalo, New York in Baird Research Park. Abcombi Biosciences is a pre-clinical vaccine and therapeutic development company dedicated to delivering “smarter” vaccine and anti-infective solutions. To accomplish this, we have developed key technologies and analytical strategies to facilitate our unique protection strategies: - Their novel biofilm model that mimics the natural progression of disease for colonizing bacteria such Streptococcus pneumoniae and Staphylococcus aureus. Bioinformatics, in conjunction with our biofilm model, help to identify antigens associated with specific stages of disease progression. - A novel coupling mechanism that removes the need for complex chemistry to manufacture polysaccharide conjugate vaccines. - A broad-spectrum RNA-based therapy for treating influenza infections. At Abcombi, we harness these potent tools to provide universally protective interventions for complex diseases such as pneumonia and influenza.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $275.0K
- Last round: Grant (Jan 2017)
- Website: abcombibio.com
- Phone: +1 716-213-8414
Industries & Categories
Biotechnology, Medical, Robotics
Social Profiles
Canonical: https://fsome.com/organization/abcombi-biosciences-190731 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.